Physician profile
Haresh Jhangiani
NPI 1578566998
$76,756.65
in general payments reported to CMS, 2019-2025
100 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $9,879 · 2021: $15K · 2022: $8,101 · 2023: $6,875 · 2024: $12K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Consulting Fee: $11K · Travel and Lodging: $1,249 · Education: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,309.07 |
| Consulting Fee | $10,822.50 |
| Travel and Lodging | $1,248.53 |
| Education | $319.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stemline Therapeutics INC. | $7,617.54 | 2019-2025 | Orserdu, Elzonris |
| Incyte Corporation | $7,180.84 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Gilead Sciences, INC. | $6,512.91 | 2019-2025 | Trodelvy |
| Coherus Oncology, INC. | $6,010.63 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $4,445.86 | 2019-2025 | Calquence, Imfinzi, Enhertu |
| Celgene Corporation | $4,324.88 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Pfizer INC. | $3,909.52 | 2019-2025 | |
| Janssen Biotech, INC. | $3,614.88 | 2019-2025 | Darzalex, Tecvayli, Imbruvica |
| Karyopharm Therapeutics INC. | $2,874.10 | 2020-2025 | Xpovio |
| Novartis Pharmaceuticals Corporation | $2,616.36 | 2019-2025 | |
| Seagen INC. | $2,101.87 | 2019-2023 | Tukysa, Tivdak, Padcev |
| Merck Sharp & Dohme LLC | $2,043.31 | 2019-2025 | Keytruda, Lynparza, Reblozyl |
| E.R. Squibb & Sons, L.L.C. | $1,487.17 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Glaxosmithkline, LLC. | $1,382.59 | 2020-2025 | Jemperli, Ojjaara, Zejula |
| Athenex Pharmaceutical Division, LLC | $1,250.00 | 2020 |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,189.57 | 2019-2023 | Nplate, Xgeva, Vectibix |
| Eisai INC. | $1,176.60 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $1,112.51 | 2019-2023 | Imbruvica, Epkinly |
| Takeda Pharmaceuticals U.S.A., INC. | $992.07 | 2019-2025 | Fruzaqla, Alunbrig, Iclusig |
| Astellas Pharma US INC | $922.04 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Bayer Healthcare Pharmaceuticals INC. | $839.97 | 2019-2025 | |
| Abbvie INC. | $805.80 | 2019-2025 | |
| Genzyme Corporation | $801.25 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $751.14 | 2019-2025 | Ultomiris |
| Puma Biotechnology, INC. | $740.43 | 2019-2025 | Nerlynx |
| Daiichi Sankyo INC. | $734.63 | 2020-2025 | Enhertu, Datroway |
| Exelixis INC. | $693.31 | 2019-2025 | Cabometyx |
| Genentech USA, INC. | $638.95 | 2019-2024 | Tecentriq, Polivy, Lunsumio |
| Beigene USA, INC. | $568.99 | 2020-2025 | Brukinsa, Tevimbra |
| Array Biopharma INC | $566.18 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Regeneron Healthcare Solutions, INC. | $444.80 | 2019-2025 | Libtayo, Lynozyfic |
| Jazz Pharmaceuticals INC. | $413.35 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $365.79 | 2019-2025 | Gilotrif |
| Lilly USA, LLC | $334.82 | 2021-2024 | Jaypirca, Verzenio, Retevmo |
| Blueprint Medicines Corporation | $304.86 | 2020-2024 | Ayvakit |
| Aveo Pharmaceuticals, INC. | $302.63 | 2021-2025 | Fotivda |
| Rigel Pharmaceuticals, INC. | $289.88 | 2019-2024 | Rezlidhia, Tavalisse |
| Kite Pharma, INC. | $281.40 | 2020-2024 | Yescarta |
| Emd Serono, INC. | $232.01 | 2019-2025 | Tepmetko |
| Taiho Oncology, INC. | $228.83 | 2020-2024 | |
| Epizyme, INC. | $198.39 | 2021-2022 | |
| Sobi, INC | $183.11 | 2021-2025 | |
| Deciphera Pharmaceuticals INC. | $162.53 | 2021-2023 | Qinlock |
| Agios Pharmaceuticals, INC. | $155.79 | 2021-2025 | Pyrukynd |
| Beone Medicines USA, INC. | $143.88 | 2025 | Brukinsa, Tevimbra |
| Tersera Therapeutics LLC | $137.43 | 2023-2025 | Zoladex, Xermelo |
| Adaptive Biotechnologies Corporation | $130.54 | 2022-2025 | Clonoseq |
| Octapharma USA, INC. | $129.82 | 2021-2023 | Panzyga |
| Myovant Sciences INC. | $128.93 | 2021-2022 | |
| Pharmaessentia USA Corporation | $126.41 | 2023-2025 | Besremi |
| Morphosys, US INC. | $106.80 | 2021-2023 | Monjuvi |
| Sanofi-Aventis U.S. LLC | $99.99 | 2022 | |
| Foundation Medicine, INC. | $95.86 | 2019-2023 | |
| Ethicon INC. | $95.61 | 2021 | |
| Clovis Oncology, INC. | $82.87 | 2019-2020 | |
| Kyowa Kirin, INC. | $80.39 | 2020-2025 | Poteligeo |
| Ipsen Biopharmaceuticals, INC | $78.78 | 2019-2025 | Onivyde, Somatuline Depot |
| Pharmacosmos Therapeutics INC. | $78.66 | 2020-2025 | Monoferric |
| Immunocore Limited | $77.33 | 2023 | Kimmtrak |
| Dendreon Pharmaceuticals LLC | $75.30 | 2019-2025 | Provenge |
| Servier Pharmaceuticals LLC | $65.43 | 2023-2025 | |
| Mirati Therapeutics, INC. | $65.05 | 2023-2024 | Krazati |
| Recordati_rare_diseases_inc. | $64.29 | 2024-2025 | Sylvant, Enjaymo |
| Spectrum Pharmaceuticals INC. | $59.60 | 2019-2025 | Rolvedon |
| Tempus Ai, INC | $54.78 | 2024 | |
| Amneal Pharmaceuticals LLC | $53.55 | 2022-2025 | Pemryri Rtu |
| Novocure INC. | $52.50 | 2020-2025 | Optune Gio |
| Verity Pharmaceuticals INC. | $52.42 | 2023-2024 | Trelstar |
| Sumitomo Pharma America, INC. | $48.28 | 2023 | Orgovyx |
| Legend Biotech USA INC. | $47.62 | 2024-2025 | Carvykti |
| Dova Pharmaceuticals | $47.30 | 2019-2021 | |
| Boston Scientific Corporation | $44.04 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Acrotech Biopharma INC. | $41.53 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $39.97 | 2019 | |
| Organon LLC | $38.79 | 2021-2022 | |
| Tesaro, INC. | $31.78 | 2019 | |
| Springworks Therapeutics, INC. | $28.52 | 2025 | Ogsiveo |
| Eusa Pharma (US) LLC | $28.39 | 2021 | |
| Cycle Pharmaceuticals INC | $28.12 | 2025 | Phyrago |
| Helsinn Therapeutics (U.S.), INC. | $27.21 | 2019 | |
| Fennec Pharmaceuticals, INC. | $26.99 | 2025 | Fyarro |
| Immunogen, INC. | $25.17 | 2024 | Elahere |
| Iovance Biotherapeutics, INC. | $24.46 | 2025 | Amtagvi |
| Catalyst Pharmaceuticals, INC. | $23.91 | 2023 | Firdapse |
| Teva Pharmaceuticals USA, INC. | $23.75 | 2019 | |
| G1 Therapeutics, INC. | $23.21 | 2022 | |
| Adc Therapeutics America, INC. | $21.60 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $21.17 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $19.27 | 2025 | Sancuso |
| Secura Bio, INC. | $18.79 | 2019-2021 | |
| Tg Therapeutics, INC. | $17.97 | 2022 | |
| Alnylam Pharmaceuticals INC. | $16.97 | 2022 | |
| Accord Healthcare, INC. | $16.74 | 2025 | |
| Myriad Genetic Laboratories, INC. | $14.54 | 2021 | |
| West Therapeutics Development, LLC | $13.87 | 2019 | |
| Ge Healthcare | $13.24 | 2021 | |
| Partner Therapeutics, INC. | $12.51 | 2020 | |
| Emmaus Medical, INC. | $12.17 | 2024 | Endari |
| Global Blood Therapeutics, INC. | $11.82 | 2020 | |
| Janssen Pharmaceuticals, INC | $6.64 | 2021 |
Drugs and devices associated with these payments
Orserdu $7,577Trodelvy $5,472Keytruda $1,111Imbruvica $1,062Darzalex $973Tecvayli $855Reblozyl $784Lenvima $658Ultomiris $568Calquence $563Brukinsa $518Enhertu $504Talvey $491Kisqali $469Jakafi $464Cabometyx $429Xpovio $377Pomalyst $367Epkinly $366Lynparza $336Fruzaqla $327Jemperli $280Sarclisa $276Nubeqa $260Opdivo $255Xtandi $239Tukysa $230Scemblix $221Ibrance $221Ojjaara $213Alunbrig $208Zepzelca $203Imfinzi $187Mektovi $178Braftovi $178Pluvicto $172Lutathera $161Monjuvi $160Piqray $155Vitrakvi $154Stivarga $154Padcev $152Carvykti $147Tivdak $146Opdualag $144Pyrukynd $141Xofigo $141Fotivda $137Besremi $126Libtayo $125Datroway $125Zejula $124Nerlynx $122Erleada $122Inlyta $119Pemazyre $109Ayvakit $109Rybrevant $109Clonoseq $107Welireg $104Rezlidhia $104Tavalisse $104Elrexfio $104Inqovi $103Lonsurf $103Comirnaty $103Lorbrena $102Tevimbra $97.63Talzenna $90.86Adcetris $88.01Elahere $86.38Venclexta $84.31Bosulif $82.05Fabhalta $81.62Paxlovid $80.54Orgovyx $80.27Kimmtrak $77.33Verzenio $76.99Jaypirca $76.99Zoladex $70.92Xermelo $66.51Tibsovo $65.43Krazati $65.05Blenrep $64.83Iclusig $63.43Poteligeo $60.00Tecentriq $59.82Ninlaro $59.81Promacta $59.25Udenyca $59.09Gilotrif $57.56Provenge $57.54Qinlock $55.54Trelstar $52.42Doptelet $52.17Shingrix $48.84Polivy $47.92Rolvedon $46.50Sylvant $45.10Therasphere Y90 Glass Microspheres 10 Gbq $44.04
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,151.04 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haresh Jhangiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.